Disparity in the Markers of Affordability Across Targeted- and Immune-Therapy Drugs Used in Head and Neck Cancers. Singh AG, Kole L, Sullivan R, Sinha S, et al. Head Neck 2026 Feb 26. doi: 10.1002/hed.70212.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Singh AG, Kole L, Sullivan R, Sinha S, et al. Disparity in the Markers of Affordability Across Targeted- and Immune-Therapy Drugs Used in Head and Neck Cancers. Head Neck 2026 Feb 26. doi: 10.1002/hed.70212.
PMID: 41748307